Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study
Titel:
Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study
Auteur:
Hellmann, Matthew D Rizvi, Naiyer A Goldman, Jonathan W Gettinger, Scott N Borghaei, Hossein Brahmer, Julie R Ready, Neal E Gerber, David E Chow, Laura Q Juergens, Rosalyn A Shepherd, Frances A Laurie, Scott A Geese, William J Agrawal, Shruti Young, Tina C Li, Xuemei Antonia, Scott J